You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 7, August 16, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Grand Rounds at the NIH Clinical Center
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (13)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Metabolic Diseases
 •Nutritional and Metabolic Disorders, Other
 •Alert me on articles by topic

Metabolic and Skeletal Complications of HIV Infection

The Price of Success

Caryn G. Morse, MD, MPH; Joseph A. Kovacs, MD

JAMA. 2006;296:844-854.

Over the past 10 years, in conjunction with the broad availability of potent antiretroviral regimens, the care of human immunodeficiency virus (HIV)–infected patients has shifted from prevention and treatment of opportunistic infections and malignancies to management of the metabolic and related complications associated with HIV infection and its treatment. Metabolic disorders, including lipodystrophy, dyslipidemia, and insulin resistance, occur at a high rate in HIV-infected individuals receiving highly active antiretroviral therapy (HAART). These disorders are associated with increased risk of cardiovascular disease and have become an important cause of morbidity and mortality in HIV-infected patients. Herein, we present the case of a patient with HIV infection who responded well to HAART but developed multiple complications potentially related to this therapy. This article reviews the clinical characteristics of the metabolic and skeletal disturbances observed in HIV infection and discusses strategies for their management.


Author Affiliations: National Institute of Allergy and Infectious Diseases–Clinical Center HIV/AIDS Program, Critical Care Medicine Department, NIH Clinical Center, Bethesda, Md.


RELATED ARTICLE

A Novel Pattern of Lipoaccumulation in HIV-Infected Men
Frank J. Palella, Jr, Joan S. Chmiel, Sharon A. Riddler, Bridget Calhoun, Adrian Dobs, Barbara Visscher, and Lawrence Kingsley
JAMA. 2006;296(7):766-768.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Drug-induced paraparotid fat deposition in patients with HIV: Case reports
Mandel and Alfi
Journal of the American Dental Association 2008;139:152-157.
ABSTRACT | FULL TEXT  

HIV-associated renal diseases in Africa a desperate need for additional study
Cohen and Kimmel
Nephrol Dial Transplant 2007;22:2116-2119.
FULL TEXT  

Lipids and Lactate in Human Immunodeficiency Virus-1 Infected Pregnancies With or Without Protease Inhibitor-Based Therapy
Livingston et al.
Obstet Gynecol 2007;110:391-397.
ABSTRACT | FULL TEXT  

Serious Non-AIDS Conditions: Redefining the Spectrum of HIV-Related Disease
AIDS Clin Care 2007;2007:1-1.
FULL TEXT  

Adipose compartmentalization and insulin resistance among obese HIV-infected women: the role of intermuscular adipose tissue
Joy and Grinspoon
Am. J. Clin. Nutr. 2007;86:5-6.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.